133 related articles for article (PubMed ID: 34619867)
1. [Clinicopathological features and prognosis of primary mediastinal large B-cell lymphoma: a series of sixty cases].
Liu HY; Zhong RQ; Zhang KP; Zhu TN; Zhong DR
Zhonghua Bing Li Xue Za Zhi; 2021 Oct; 50(10):1139-1144. PubMed ID: 34619867
[No Abstract] [Full Text] [Related]
2. Identification of Primary Mediastinal Large B-cell Lymphoma at Nonmediastinal Sites by Gene Expression Profiling.
Yuan J; Wright G; Rosenwald A; Steidl C; Gascoyne RD; Connors JM; Mottok A; Weisenburger DD; Greiner TC; Fu K; Smith L; Rimsza LM; Jaffe ES; Campo E; Martinez A; Delabie J; Braziel RM; Cook JR; Ott G; Vose JM; Staudt LM; Chan WC;
Am J Surg Pathol; 2015 Oct; 39(10):1322-30. PubMed ID: 26135560
[TBL] [Abstract][Full Text] [Related]
3. Expression pattern of PD-L1 and PD-L2 in classical Hodgkin lymphoma, primary mediastinal large B-cell lymphoma, and gray zone lymphoma.
Tanaka Y; Maeshima AM; Nomoto J; Makita S; Fukuhara S; Munakata W; Maruyama D; Tobinai K; Kobayashi Y
Eur J Haematol; 2018 May; 100(5):511-517. PubMed ID: 29377256
[TBL] [Abstract][Full Text] [Related]
4. Primary mediastinal large B-cell lymphoma: transcriptional regulation by miR-92a through FOXP1 targeting.
Romero M; Gapihan G; Castro-Vega LJ; Acevedo A; Wang L; Li ZW; El Bouchtaoui M; Di Benedetto M; Ratajczak P; Feugeas JP; Thieblemont C; Saavedra C; Janin A
Oncotarget; 2017 Mar; 8(10):16243-16258. PubMed ID: 27806315
[TBL] [Abstract][Full Text] [Related]
5. [Primary mediastinal large B-cell lymphoma: a clinicopathologic study of 27 cases].
Shi QY; Feng X; Chen H; Ma HH; Lu ZF; Shi QL; Zhou XJ; Shen Q
Zhonghua Bing Li Xue Za Zhi; 2017 Sep; 46(9):607-612. PubMed ID: 28910870
[No Abstract] [Full Text] [Related]
6. The immunophenotypic spectrum of primary mediastinal large B-cell lymphoma reveals prognostic biomarkers associated with outcome.
Bledsoe JR; Redd RA; Hasserjian RP; Soumerai JD; Nishino HT; Boyer DF; Ferry JA; Zukerberg LR; Harris NL; Abramson JS; Sohani AR
Am J Hematol; 2016 Oct; 91(10):E436-41. PubMed ID: 27419920
[TBL] [Abstract][Full Text] [Related]
7. Characterization of DLBCL with a PMBL gene expression signature.
Duns G; Viganò E; Ennishi D; Sarkozy C; Hung SS; Chavez E; Takata K; Rushton C; Jiang A; Ben-Neriah S; Woolcock BW; Slack GW; Hsi ED; Craig JW; Hilton LK; Shah SP; Farinha P; Mottok A; Gascoyne RD; Morin RD; Savage KJ; Scott DW; Steidl C
Blood; 2021 Jul; 138(2):136-148. PubMed ID: 33684939
[TBL] [Abstract][Full Text] [Related]
8. Primary mediastinal large B-cell lymphoma. A clinicopathologic study of 141 cases compared with 916 nonmediastinal large B-cell lymphomas, a GELA ("Groupe d'Etude des Lymphomes de l'Adulte") study.
Cazals-Hatem D; Lepage E; Brice P; Ferrant A; d'Agay MF; Baumelou E; Brière J; Blanc M; Gaulard P; Biron P; Schlaifer D; Diebold J; Audouin J
Am J Surg Pathol; 1996 Jul; 20(7):877-88. PubMed ID: 8669537
[TBL] [Abstract][Full Text] [Related]
9. Clinical Significance of
Ting CY; Chang KM; Kuan JW; Sathar J; Chew LP; Wong OJ; Yusuf Y; Wong L; Samsudin AT; Pana MNBM; Lee SK; Gopal NSR; Puri R; Ong TC; Bahari SK; Goh AS; Teoh CS
Int J Med Sci; 2019; 16(4):556-566. PubMed ID: 31171907
[No Abstract] [Full Text] [Related]
10. The utility of CD83, fascin and CD23 in the differential diagnosis of primary mediastinal large B-cell lymphoma versus classic Hodgkin lymphoma.
Aladily TN; Mansour A; Alsughayer A; Sughayer M; Medeiros LJ
Ann Diagn Pathol; 2019 Jun; 40():72-76. PubMed ID: 31075666
[TBL] [Abstract][Full Text] [Related]
11. [Survival of patients with primary central nervous system diffuse large B-cell lymphoma: impact of gene aberrations and protein overexpression of bcl-2 and C-MYC, and selection of chemotherapy regimens].
Yin WJ; Zhu X; Yang HY; Sun WY; Wu MJ
Zhonghua Bing Li Xue Za Zhi; 2018 Jan; 47(1):32-38. PubMed ID: 29325248
[No Abstract] [Full Text] [Related]
12. [Retrospective analysis of the clinical features and prognostic factors of 370 patients with advanced-stage diffuse large B-cell lymphoma].
Han Y; Qin Y; He XH; Yang JL; Liu P; Zhang CG; Zhou LQ; Zhou SY; Gui L; Song YW; Sun Y; Shi YK
Zhonghua Zhong Liu Za Zhi; 2018 Jun; 40(6):456-461. PubMed ID: 29936773
[No Abstract] [Full Text] [Related]
13. Pathobiology of primary mediastinal B-cell lymphoma.
Pileri SA; Zinzani PL; Gaidano G; Falini B; Gaulard P; Zucca E; Sabattini E; Ascani S; Rossi M; Cavalli F;
Leuk Lymphoma; 2003; 44 Suppl 3():S21-6. PubMed ID: 15202521
[TBL] [Abstract][Full Text] [Related]
14. Clinical Features and Therapeutic Outcomes Comparing Primary Mediastinal Large B-cell Lymphoma to Mediastinal Hodgkin Disease.
Cruz-Chamorro RJ; Rodríguez-López JL; González-Soto MJ; Arroyo-Suárez R; Ortiz-Sánchez C; Encarnación-Medina J; Cabanillas F
P R Health Sci J; 2024 Jun; 43(2):79-83. PubMed ID: 38860961
[TBL] [Abstract][Full Text] [Related]
15. Primary mediastinal B-cell lymphoma: hypermutation of the BCL6 gene targets motifs different from those in diffuse large B-cell and follicular lymphomas.
Malpeli G; Barbi S; Moore PS; Scardoni M; Chilosi M; Scarpa A; Menestrina F
Haematologica; 2004 Sep; 89(9):1091-9. PubMed ID: 15377470
[TBL] [Abstract][Full Text] [Related]
16. [Expression of dendritic cell marker CD21 is a positive prognostic factor in diffuse large B-cell lymphoma].
Yao WK; Wang YP; Peng F; Zheng Y; Zou YB; Gao JN; Liu XL
Zhonghua Bing Li Xue Za Zhi; 2012 Dec; 41(12):818-22. PubMed ID: 23324230
[TBL] [Abstract][Full Text] [Related]
17. Primary mediastinal B-cell lymphoma: a review of pathology and management.
van Besien K; Kelta M; Bahaguna P
J Clin Oncol; 2001 Mar; 19(6):1855-64. PubMed ID: 11251018
[TBL] [Abstract][Full Text] [Related]
18. Brentuximab vedotin demonstrates an objective response in a patient with refractory CD30+ primary mediastinal B-cell lymphoma.
Badri N; Ngamdu KS; Torabi A; Guar S
J Cancer Res Ther; 2020; 16(1):183-185. PubMed ID: 32362635
[TBL] [Abstract][Full Text] [Related]
19. Molecular diagnosis of primary mediastinal B cell lymphoma identifies a clinically favorable subgroup of diffuse large B cell lymphoma related to Hodgkin lymphoma.
Rosenwald A; Wright G; Leroy K; Yu X; Gaulard P; Gascoyne RD; Chan WC; Zhao T; Haioun C; Greiner TC; Weisenburger DD; Lynch JC; Vose J; Armitage JO; Smeland EB; Kvaloy S; Holte H; Delabie J; Campo E; Montserrat E; Lopez-Guillermo A; Ott G; Muller-Hermelink HK; Connors JM; Braziel R; Grogan TM; Fisher RI; Miller TP; LeBlanc M; Chiorazzi M; Zhao H; Yang L; Powell J; Wilson WH; Jaffe ES; Simon R; Klausner RD; Staudt LM
J Exp Med; 2003 Sep; 198(6):851-62. PubMed ID: 12975453
[TBL] [Abstract][Full Text] [Related]
20. [Clinical characteristics and prognosis of concurrent positive t(14; 18) and myc gene rearrangement in diffuse large B cell lymphoma].
Zhang HW; Chen ZW; Wang LY; He JX; Zheng YP; Han WE; Yang B; Wang YL; Zhao ZQ; Bai M; Su LP
Zhonghua Zhong Liu Za Zhi; 2016 Mar; 38(3):206-10. PubMed ID: 26988827
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
